Changeflow GovPing Healthcare & Life Sciences Enhancing Letter-Speech Sound Learning and Read...
Routine Notice Added Final

Enhancing Letter-Speech Sound Learning and Reading Network Activation With Transcranial Electrical Stimulation

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

NIH ClinicalTrials.gov registered a Phase N/A interventional study (NCT07546292) titled 'Enhancing Letter-Speech Sound Learning and Reading Network Activation With Transcranial Electrical Stimulation.' The trial investigates transcranial random noise stimulation (tRNS) versus sham stimulation in adult participants across a range of reading abilities, using an artificial orthography learning task that simulates letter-speech sound learning, a skill impaired in developmental dyslexia. Conditions listed include Developmental Dyslexia, Reading, Learning, and Learning Disabilities. Enrollment status and specific participant numbers are not disclosed in the registry entry; the posted date is April 22, 2026.

“This study investigates the effects of transcranial electrical stimulation (tES) on the brain and its potential to enhance reading-related learning.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 627 changes logged to date.

What changed

The NIH ClinicalTrials.gov registry added a new observational trial record (NCT07546292) for a study examining transcranial electrical stimulation as a potential aid for letter-speech sound learning in adults with developmental dyslexia. The trial lists two arms — active transcranial random noise stimulation (tRNS) and sham stimulation — and will use both behavioral measures and functional MRI to assess outcomes. Conditions include Developmental Dyslexia, Reading, Learning, and Learning Disabilities. This registry entry does not create compliance obligations. Readers should note that ClinicalTrials.gov entries reflect study registration intent; they do not constitute FDA approval, endorsement of the device, or authorization to proceed clinically.

For compliance officers and clinical research professionals, this entry signals ongoing investigation into non-invasive neuromodulation for reading-related learning disabilities. Sponsors or institutions conducting similar cognitive/neurorehabilitation trials should monitor this study for future results publication, as positive findings could inform IRB submissions or device-investigation protocols. The trial does not impose reporting or disclosure requirements on external parties.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Enhancing Letter-Speech Sound Learning and Reading Network Activation With Transcranial Electrical Stimulation

N/A NCT07546292 Kind: NA Apr 22, 2026

Abstract

This study investigates the effects of transcranial electrical stimulation (tES) on the brain and its potential to enhance reading-related learning. Adult participants with a range of reading abilities will receive transcranial random noise stimulation (tRNS) while they perform an artificial orthography learning task. This task simulates letter-speech sound learning, an important first step during reading acquisition known to be impaired in individuals with developmental dyslexia. The effects of the intervention will be assessed using both behavioral measures and functional magnetic resonance imaging (fMRI).

Conditions: Dyslexia, Developmental, Reading, Dyslexia, Learning, Learning Disabilities

Interventions: Transcranial random noise stimulation, Sham Stimulation

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Neuromodulation research Dyslexia intervention study
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Medical Devices Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!